Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer

PURPOSE: Hormone receptor (HR)-positive, Human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) requires a therapeutic approach that takes into account multiple factors, with treatment being based on anti-estrogen hormone therapy (HT). As consensus documents are valu...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez-Lopez, I., Bezares, S., Dalmau Portulas, E., García-Martínez, E., García-Sáenz, J. Á., Gil-Gil, M., Martínez de Dueñas, E., Ribelles, N., Santaballa Bertrán, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316841/
https://www.ncbi.nlm.nih.gov/pubmed/32052382
http://dx.doi.org/10.1007/s12094-019-02269-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316841/
https://www.ncbi.nlm.nih.gov/pubmed/32052382
http://dx.doi.org/10.1007/s12094-019-02269-7

Ejemplares similares